LifeStance Health Group Inc (LFST) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and ... [Yahoo! Finance]
LifeStance Health Group, Inc. (LFST)
Company Research
Source: Yahoo! Finance
Clinician Growth: Increased by 285 net clinicians, totaling 7,269, a 13% year-over-year growth. Visit Volumes: 2 million visits, a 15% increase year-over-year. Total Revenue per Visit: Increased 3% year-over-year to $159. Center Margin: $100 million, a 32% increase year-over-year. Adjusted EBITDA: $31 million, a 110% increase year-over-year, representing 9.8% of revenue. Free Cash Flow: $18 million generated in the third quarter. Cash and Debt: $103 million in cash and net long-term debt of $279 million. Days Sales Outstanding (DSO): Improved by 2 days to 47 days. Full Year Revenue Guidance: Raised to $1.228 billion to $1.248 billion. Full Year Center Margin Guidance: Raised to $382 million to $398 million. Full Year Adjusted EBITDA Guidance: Raised to $105 million to $115 million. Fourth Quarter Revenue Guidance: $302.5 million to $322.5 million. Fourth Quarter Center Margin Guidance: $89 million to $105 million. Fourth Quarter Adjusted EBITDA Guidance: $18
Show less
Read more
Impact Snapshot
Event Time:
LFST
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LFST alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LFST alerts
High impacting LifeStance Health Group, Inc. news events
Weekly update
A roundup of the hottest topics
LFST
News
- LifeStance Health Group, Inc. (NASDAQ: LFST) was upgraded by analysts at The Goldman Sachs Group, Inc. from a "neutral" rating to a "buy" rating. They now have a $10.00 price target on the stock.MarketBeat
- Zarminali Health Launches with $40M in Seed Funding to Transform Pediatric Care through Nationwide, Multi-specialty Practice Group [Yahoo! Finance]Yahoo! Finance
- Zarminali Health Launches with $40M in Seed Funding to Transform Pediatric Care through Nationwide, Multi-specialty Practice GroupGlobeNewswire
- LifeStance Health Group, Inc. (NASDAQ: LFST) had its price target raised by analysts at Barclays PLC from $6.00 to $7.00. They now have an "underweight" rating on the stock.MarketBeat
- LifeStance Reports Third Quarter 2024 ResultsGlobeNewswire
LFST
Earnings
- 11/7/24 - Beat
LFST
Sec Filings
- 12/19/24 - Form 8-K
- 12/2/24 - Form 4
- 11/27/24 - Form 144
- LFST's page on the SEC website